Justin N Corcoran
Overview
Explore the profile of Justin N Corcoran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
8
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Corcoran J, Jacoby K, Olives T, Bangh S, Cole J
J Med Toxicol
. 2021 Feb;
17(2):235-236.
PMID: 33595807
No abstract available.
2.
Cole J, Corcoran J
Cardiol Young
. 2020 Nov;
30(11):1755-1756.
PMID: 33168127
No abstract available.
3.
Corcoran J, Jacoby K, Olives T, Bangh S, Cole J
J Med Toxicol
. 2020 Jul;
16(4):465-469.
PMID: 32656624
Introduction: Overdoses of beta-adrenergic antagonists and calcium channel antagonists represent an uncommonly encountered but highly morbid clinical presentation. Potential therapies include fluids, calcium salts, vasopressors, intravenous lipid emulsion, methylene blue,...
4.
LeRoy J, Boley S, Corcoran J, Engebretsen K, Stellpflug S
J Med Toxicol
. 2020 Jun;
16(4):398-404.
PMID: 32495116
Introduction: Calcium channel blocker (CCB) overdoses cause significant morbidity and mortality. Dihydropyridine CCBs cause peripheral vascular dilation and at high doses cardiac dysfunction. Amlodipine, a dihydropyridine, causes peripheral vasodilation from...
5.
Cole J, Corcoran J, Engebretsen K, Stellpflug S
J Med Toxicol
. 2020 Jan;
16(2):212-221.
PMID: 31981076
Introduction: Vasopressors are a commonly used treatment in beta-blocker poisoning despite evidence they may be ineffective or harmful. The primary objective of the present study is to use previously collected...